Loading clinical trials...
Loading clinical trials...
Feasibility and Clinical Results of Implementation of ERAS® Guidelines for Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: an International Prospective Cohort Study
Conditions
Interventions
Pre-ERAS® phase (current clinical practice)
Post-ERAS® implementation phase
Locations
3
United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
University of Calgary, Arnie Charbonneau Cancer Institute
Calgary, Alberta, Canada
Lausanne University Hospital
Lausanne, Switzerland
Start Date
October 1, 2021
Primary Completion Date
June 30, 2022
Completion Date
August 31, 2022
Last Updated
January 11, 2022
Lead Sponsor
Hospices Civils de Lyon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions